Results 11 to 20 of about 2,312,760 (293)

Antibody-mediated rejection in heart transplantation [PDF]

open access: yesВестник трансплантологии и искусственных органов, 2022
The role of antibody-mediated rejection in predicting survival among heart recipients has been studied in clinical transplantology for over 20 years. This condition is a significant risk factor for heart failure and graft vasculopathy.
V. S. Kvan   +6 more
doaj   +2 more sources

Antibody-mediated rejection in the liver allograft

open access: yesCurrent Opinion in Organ Transplantation, 2012
Purpose of review There is increasing evidence to suggest that antibody-mediated mechanisms play a role in the pathogenesis of liver allograft rejection. This article will review the pathology of antibody-mediated rejection (AMR) focusing on recent studies which have improved our understanding of the clinicopathological ...
Hübscher, Stefan G
openaire   +3 more sources

Late antibody-mediated rejection in a kidney transplant recipient: COVID 19 induced? [PDF]

open access: yesBMC Nephrology, 2022
Background Antibody-mediated rejection (AMR) was described in kidney transplant patients after viral infections, such as the cytomegalovirus. Very few cases were recently reported after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 ...
Nicole Nourié   +6 more
doaj   +2 more sources

Diagnosis and treatment of acute antibody-mediated rejection in renal transplant: the role of C4d and donor-specific antibody identification [PDF]

open access: yesEinstein (São Paulo), 2009
Objective: To evaluate the incidence of antibody-mediated rejection after the C4d  and  donor specific antibody  detection was provided by Luminex in renal transplantation biopsies; to compare acute antibody-mediated  rejection characteristics as related
Lúcio Roberto Requião Moura   +8 more
doaj   +1 more source

Antibody-Mediated Rejection: A Review.

open access: yesOchsner journal, 2017
Chronic antibody injury is a serious threat to allograft outcomes and is therefore the center of active research. In the continuum of allograft rejection, the development of antibodies plays a critical role. In recent years, an increased recognition of molecular and histologic changes has provided a better understanding of antibody-mediated rejection ...
Garces, Jorge Carlos   +5 more
openaire   +5 more sources

Efficacy of deoxyspergualine for antibody-mediated rejection and proteinuria after kidney transplantation

open access: yesTherapeutics and Clinical Risk Management, 2008
Hideki Ishida, Kazunari TanabeDepartment of Urology, Tokyo Women’s Medical University, Tokyo, JapanAbstract: A patient showing antibody-mediated rejection (AMR) with severe vasculitis, and massive proteinuria after kidney transplantation was ...
Hideki Ishida, Kazunari Tanabe
doaj   +1 more source

ACCELERATED HUMORAL (ANTIBODY-MEDIATED) REJECTION OF THE CARDIAC ALLOGRAFT (A CASE REPORT) [PDF]

open access: yesВестник трансплантологии и искусственных органов, 2011
In the article there is described the case of the accelerated humoral (antibody-mediated) rejection of the cardiac allograft with morphologic and immunohistochemical details revealed at the investigation of the endomyocardial biopsy and myocardial ...
A. G. Kupriyanova   +6 more
doaj   +2 more sources

Pathology of Antibody-Mediated Rejection

open access: yes, 2016
Antibody-mediated rejection (AMR) is now recognized as an important clinical complication of pediatric and adult cardiac transplantation. In addition to causing graft dysfunction, it has been associated with the accelerated development of transplant vasculopathy and graft loss.
Samuel Rotman   +3 more
openaire   +2 more sources

Editorial: Antibody-mediated rejection

open access: yesFrontiers in Transplantation
Ramsey R. Hachem   +1 more
doaj   +3 more sources

Antibody-mediated rejection-treatment standard. [PDF]

open access: yesNephrol Dial Transplant
ABSTRACT Antibody-mediated rejection (AMR) remains a major cause of graft failure, with significant health and economic burden. Despite being recognized >25 years ago, AMR treatment remains unstandardized, and no therapy has gained robust regulatory approval.
Böhmig GA   +6 more
europepmc   +5 more sources

Home - About - Disclaimer - Privacy